O
Ora Clinical | Retina Consultants of Nashville
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
RO7200220
Ranibizumab
Vamikibart
Parent organization
This site is a part of Ora Clinical
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD
This study will compare the efficacy and safety of HLX04-O administered by intravitreal injection (IVT) with ranibizumab in patients with active wAMD.
Active, not recruiting
Age Related Macular Degeneration
Drug: HLX04-O
Drug: ranibizumab
Study BP43445 is a phase II, multicenter, randomized, double-masked, active comparator-controlled study to investigate the efficacy, safety, tolerabi...
Active, not recruiting
Diabetic Macular Edema
Drug: Ranibizumab
Drug: Vamikibart
Trial sponsors
H
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems